This indicates that FGF17 facilitates the migration and invasion of cancer cells through sustaining glutamine metabolism and supporting α-KG-driven TCA cycle activity, further confirming its intervention in metabolic reprogramming during NSCLC progression. The gene discussed is FGF17; the disease is cancer.